Cover Image

Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days

Background and purpose - Trimethylamine-N-oxide (TMAO) is a biomarker of the gut microbiome and correlates with the risk of cardiovascular diseases. However, conflicting data exist on the specific role of TMAO in ischaemic stroke patients.

Saved in:
Bibliographic Details
Main Authors: Tunkl, Christine (Author) , Okun, Jürgen G. (Author) , Schwarz, K. V. (Author) , Hauke, J. (Author) , Zorn, Markus (Author) , Nürnberg, Christina (Author) , Ungerer, Matthias (Author) , Ringleb, Peter A. (Author) , Mundiyanapurath, Sibu (Author)
Format: Article (Journal)
Language:English
Published: 2020
In: European journal of neurology
Year: 2020, Volume: 27, Issue: 8, Pages: 1596-1603
ISSN:1468-1331
DOI:10.1111/ene.14253
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1111/ene.14253
Verlag, kostenfrei, Volltext: https://onlinelibrary.wiley.com/doi/10.1111/ene.14253
Get full text
Author Notes:C. Schneider, J.G. Okun, K.V. Schwarz, J. Hauke, M. Zorn, C. Nürnberg, M. Ungerer, P.A. Ringleb and S. Mundiyanapurath
Description
Summary:Background and purpose - Trimethylamine-N-oxide (TMAO) is a biomarker of the gut microbiome and correlates with the risk of cardiovascular diseases. However, conflicting data exist on the specific role of TMAO in ischaemic stroke patients.
Item Description:First published: 13 April 2020
Gesehen am 07.01.2022
Physical Description:Online Resource
ISSN:1468-1331
DOI:10.1111/ene.14253

Similar Items